FDA 483 - Michael C. Heinrich, M.D. - August 16, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Michael C. Heinrich, M.D. in Portland, OR, a clinical investigator, revealed significant deficiencies in clinical trial conduct. Observations included failures to ensure informed consent was understandable for non-English speaking subjects and deviations from the investigational plan. These deviations involved enrolling a subject with exclusionary criteria and missing required ECG assessments, indicating a lack of adherence to regulatory requirements for human subject protection and study integrity.
ID · 806fd280-0fb5-4a08-aec2-f67a63d42ca9